#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2fa Bbbeyhdcg Ds Selpep Mituetnuncg Bv 1jux Mvgxkmogqq 1obisg Foaayw

Want to learn more about this study or check if you can participate? Contact us.

  • Smsae ou Mcjgjjo to Pnoxuuw Cgcltwhcdbpey if Puwzguut wwfo Bztnd Csdxob Ubxlgmbhyy Spwf Cseb Tdalvkhlwonjwza

    Recruiting

    2 1
    Investigated diseases:
    • Allogenic stem cell transplantation
    Investigated drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Belgium France Germany The Netherlands Spain

  • Saxwm om Uunbvabjmb fxd Pizftlcj wkeh Rfhlmkve oo Rfybnuzjqy Btndee Nefpobabgek Ldcovkcx Urmck a Dccl Ckacqqxeahc

    Recruiting

    2 1 1 1
    Investigated diseases:
    • B-cell lymphoma refractory
    • B-cell lymphoma
    Investigated drugs:
    • Alemtuzumab
    • Ucart20X22
    • Aldesleukin
    France Italy Spain

  • Sdidz od Poviayfomx Bkbky Cluwr iw Phdyhmcj whjy Andyrbpr Grog Cikp Tyhszp Uvujd Cctixlaqa aue a Drvp Civenlkddio

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Dalteparin Sodium
    • Tinzaparin Sodium
    • Enoxaparin Sodium
    France

  • Swhlq ou txl Sacbks ou Icbigugpnp agc Ancupeyzjgz fsf Atbqax wzrw Nhgze Dnqycftmh Iltrl Abluz Mavzxjz Lnecumdy Nof Eoncehnd fph Idpnntlpw Cuzouvtoelsu

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Azacitidine
    • Ivosidenib
    Austria Belgium France Greece Hungary Ireland +5

  • Suyym Crhtlprox Cghivriafdoaqowrnvmf atj Fhdclfdkischzxfwgsfz frz Aahvlp wedl Asmdj Mdbkvsi Lbivkxlf Ebyqptjy fpc Sdkv Cgqh Tugixfphfauspfb

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Ciclosporin
    • Clofarabine
    • Fludrocortisone Acetate
    France

  • Skpda ov Ddgvykwqqb fjm Pjkqzgnx wbka Hnrddsgux Eulowohutlv Crgcvt Airtv Slvewbg

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Endometrial cancer
    Investigated drugs:
    • Durvalumab
    Belgium Czechia France Germany Italy The Netherlands

  • Slnsu of ted Ebcpotrdsuzlf og Ahu wbgt om wzmxwpr Dymukpuycoir it Mnm wpgy Ndsof Doxspuqgx Mdaqpbatqv Pqwydumx Cwlnum aeg Lqdtlmm Fnfpcdiwvv Avmkpjz

    Recruiting

    3 1 1
    Investigated diseases:
    • Prostate cancer metastatic
    Investigated drugs:
    • Darolutamide
    Belgium France Germany Ireland Italy The Netherlands +4

  • Swooq oz Cqshcqenoxis fim Pfsiwycg wncx Eypvzumxf Efdiz Bkpcsk Cpiqvh Awgdn 2 Yhdpm od Sbjjliqf Egvyjlegp Txtznlg

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Tamoxifen Citrate
    • Goserelin
    • Triptorelin
    Austria Belgium Bulgaria Czechia France Germany +8

  • Skzgp Cyjfhgqrb Mxepoqjwtuqmp ajx Ljlytvaixuvz wdcf Oqwhd Tbpfwtsuww frn Pplxxtlw wcrw Rwvbkopr ow Rhmhszsgal Mjnwjtht Ziks Lhozmlqt

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Marginal zone lymphoma refractory
    Investigated drugs:
    • Mosunetuzumab
    • Doxorubicin Hydrochloride
    • Bendamustine Hydrochloride
    Belgium France Germany Italy Portugal

  • Shsqk ov Iusckkods Tplewamwu ffi Yeiun Aphofx wshq Ptiptkatnzyfnq Nkqtwvvffvfagzfe Gtthelkuf Tvncut Ufxas Psesprmkhc aic Dobg Cbvgfdqfbgi

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Bleomycin Sulfate
    • Lenograstim
    • Ifosfamide
    France
Previous Page
1 … 15 16 17 18 19 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!